---
category: market-operations
circular_id: 9fc33128d37a1fc0
date: '2025-12-12'
description: NSE announces Enhanced Surveillance Measure changes effective December
  15-16, 2025, including addition of Alps Industries to ESM Stage-I, movement of Saakshi
  Medtech from Stage-II to Stage-I, and exclusion of Aarey Drugs from the framework.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/SURV71785.zip
impact: high
impact_ranking: high
importance_ranking: high
justification: High importance due to mandatory 100% margin requirement and shift
  to Trade-for-Trade segment affecting trading in specified securities, with immediate
  impact on market participants' positions and trading mechanisms
pdf_url: https://nsearchives.nseindia.com/content/circulars/SURV71785.zip
processing:
  attempts: 1
  content_hash: ca2cfbb88199b13e
  processed_at: '2025-12-12T13:02:07.966929'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-12T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/SURV71785.zip
severity: high
source: nse
stocks:
- ALPSINDUS
- SAAKSHI
- AAREYDRUGS
tags:
- enhanced-surveillance-measure
- esm
- surveillance
- trade-for-trade
- margin-requirement
- price-band
- periodic-call-auction
title: Applicability of Enhanced Surveillance Measure (ESM) - December 2025
---

## Summary

NSE has issued updates to the Enhanced Surveillance Measure (ESM) framework effective December 15-16, 2025. Alps Industries Limited will be added to ESM Stage-I with a shift from rolling settlement (EQ/SM) to Trade-for-Trade segment (BE/ST) and 100% margin requirement. Saakshi Medtech and Panels Limited moves from ESM Stage-II to Stage-I. Aarey Drugs & Pharmaceuticals Limited is being excluded from the ESM framework entirely.

## Key Points

- Alps Industries Limited (ALPSINDUS, ISIN: INE093B01015) added to ESM Stage-I effective December 15, 2025
- 100% minimum margin applicable on all open positions as on December 15, 2025 and new positions from December 16, 2025
- Securities in ESM shifted from Rolling Settlement segment (EQ/SM) to Trade-for-Trade segment (BE/ST) from December 16, 2025
- Saakshi Medtech and Panels Limited (SAAKSHI, ISIN: INE0PSK01027) moves from ESM Stage-II to Stage-I effective December 15, 2025
- Securities moving to Stage-II will be under Trade-for-Trade with 2% price band under Periodic Call Auction from December 15, 2025
- Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS, ISIN: INE198H01019) excluded from ESM framework from December 15, 2025
- ESM framework operates in conjunction with all other prevailing surveillance measures

## Regulatory Changes

The Enhanced Surveillance Measure (ESM) framework continues with modifications to the list of securities under surveillance. Securities qualifying under ESM are subject to:

- Mandatory 100% margin requirement
- Migration from rolling settlement to Trade-for-Trade segment
- For Stage-II securities: 2% price band restriction under Periodic Call Auction mechanism
- Price bands for securities exiting the framework will be reinstated to pre-ESM levels, unless subject to other surveillance measures

## Compliance Requirements

- Members must ensure 100% margin is collected on all open positions in affected securities as on December 15, 2025
- 100% margin must be collected on all new positions created from December 16, 2025 in ESM securities
- Trading in Alps Industries Limited must shift to Trade-for-Trade (BE/ST series) from December 16, 2025
- Members must note that ESM shortlisting is purely for market surveillance purposes and not an adverse action against the company
- Members should refer to consolidated list in Annexure III for complete ESM securities list

## Important Dates

- **December 12, 2025**: Circular issued
- **December 15, 2025**: ESM changes become effective; 100% margin applicable on open positions; Stage-II securities shift to Trade-for-Trade with 2% price band under Periodic Call Auction
- **December 16, 2025**: 100% margin applicable on new positions; Alps Industries shifts from EQ/SM to BE/ST segment

## Impact Assessment

**Market Impact:**
- Increased margin requirements of 100% will significantly impact liquidity and trading volumes in Alps Industries
- Shift to Trade-for-Trade segment eliminates intraday trading and speculative activity
- Exclusion of Aarey Drugs from ESM provides relief and restored normal trading conditions

**Operational Impact:**
- Brokers and members must adjust margin collection systems for affected securities
- Risk management systems need updates to reflect new margin requirements
- Settlement processes change from rolling to trade-for-trade for Alps Industries

**Investor Impact:**
- Investors holding positions in Alps Industries face 100% margin requirement
- No intraday trading possible in Trade-for-Trade segment
- Reduced liquidity and increased transaction costs in ESM securities
- Positive impact for Aarey Drugs investors with removal of restrictions

The surveillance measure is designed to curb excessive speculation and price manipulation while maintaining market integrity.